US Patent 7402431 T-cell therapy formulation
Patent 7402431 was granted and assigned to Immunovative Therapies on July, 2008 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7402431 T-cell therapy formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.